Caribou Biosciences

Forecast & Rating7 analysts currently cover Caribou Biosciences, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $11.86, about 717.7% upside from the current price of $1.45. Price targets range from $4.00 to $32.00 — a wide spread, showing clear disagreement over just how much Caribou Biosciences can rise. Historically, about 1.9% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Caribou Biosciences closely still see room for the stock to rise. Data as of Aug 14, 2026; for reference only and not investment advice.